Form 4: Olema Pharmaceuticals Director Receives Stock Options

Director Prakash Raman was granted stock options for 27,061 shares of Olema Pharmaceuticals common stock.

Summary

• Director Prakash Raman received two grants of stock options totaling 27,061 shares.
• The options have an exercise price of $14.59 per share.
• The grants consist of 2,911 shares vesting on June 11, 2026, and 24,150 shares vesting in 36 equal monthly installments starting April 28, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative disclosure regarding director compensation, which is neutral in terms of immediate market impact.

Positives

• Alignment of director interests with long-term shareholder value through equity-based compensation.

Negatives

• Issuance of stock options results in potential future dilution for existing shareholders.

Risks

• Vesting is contingent upon the director's continuous service to the company.

Future Outlook

The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of director equity compensation.

Industry Context

StockSavvy.ai notes that equity grants to directors are standard practice in the biotechnology sector to incentivize board members and align their interests with long-term corporate performance.

Comparison to Industry Standards

• The use of multi-year vesting schedules for director options is consistent with standard corporate governance practices in the U.S. biotech industry.
• The exercise price reflects the market value at the time of the grant, adhering to standard regulatory requirements.

Stakeholder Impact

• Shareholders may experience minor dilution upon the eventual exercise of these options.

Next Steps

• Vesting of 2,911 shares on June 11, 2026.
• Commencement of monthly vesting for 24,150 shares.

Key Dates

Keywords

Olema Pharmaceuticals, OLMA, Form 4, Insider Trading, Stock Options, Director Compensation